NCT06237647 Comparison of Steroid, PRP,and PRP Plus Hyaluronic Acid Injection for Rotator Cuff Lesions.
| NCT ID | NCT06237647 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tien-Ching Lee |
| Condition | Rotator Cuff Lesions |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2023-02-17 |
| Primary Completion | 2027-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2023-02-17 with a primary completion date of 2027-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Rotator cuff tear is a common cause of shoulder pain. Steroids, hyaluronic acid (HA), and platelet-rich plasma (PRP) injections are becoming popular for the treatment of chronic rotator cuff partial tear. The investigators plan to evaluate the effect of the new product of PRP combined with HA on the rotator cuff and prove its benefit of pain control and function recovery.
Eligibility Criteria
Inclusion Criteria: * A. Shoulder pain for at least 1 months * B.partial-thickness tear diagnosed by MRI or Echo * C.age between 20 and 85 years old Exclusion Criteria: * A. inflammatory disease, such as rheumatoid arthritis, SLE, etc. * B. pregnancy * C. known malignancy * D. hematologic disease (or hemoglobin \<10 g/dl, platelet \<150.000 ul) * E. history of shoulder infection * F. history of shoulder surgery * G. prior steroid injection for 3 times or more * H. full-thickness tear * I. other shoulder problems, such as osteoarthritis, fracture malunion, etc. * J. subjects who cannot comply with the protocol of study * K. The shoulder pain area has been treated with PRP for less than 3 months
Frequently Asked Questions
Who can join the NCT06237647 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 85 Years, studying Rotator Cuff Lesions. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06237647 currently recruiting?
Yes, NCT06237647 is actively recruiting participants. Visit ClinicalTrials.gov or contact Tien-Ching Lee to inquire about joining.
Where is the NCT06237647 trial being conducted?
This trial is being conducted at Kaohsiung City, Taiwan.
Who is sponsoring the NCT06237647 clinical trial?
NCT06237647 is sponsored by Tien-Ching Lee. The trial plans to enroll 80 participants.